DECEMBER 2022 Research Alert

This month we added four new studies to the Best Practice Database, the research repository for Best Practices, LLC. This month's new studies explore two topical areas: maximizing investigator-initiated studies capabilities and benchmarking real-world uses of AI in Medical Affairs. The first two studies assist biopharma organizations benchmark their IIS program management and investment. The last two studies examine how top companies are applying AI within Medical Affairs to maximize impact.

The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.

	Download: Benchmarking IIS Strategy: Investigator-Initiated and Collaborative Studies Management (5743) This Best Practices, LLC study examines the strategies, resources and activities surrounding investigator-initiated studies (IISs) and collaborative studies which are needed to help Medical Affairs and Clinical Development groups gain support for IIS programs and maximize the potential of their drug portfolios.
	Download: Benchmarking IIS Strategy: Investigator-Initiated Studies for Pre-Approval Compounds (5744) Best Practices, LLC undertook this benchmarking research to develop key metrics for comparing various factors related to investigator-initiated studies (IISs) for pre-approval compounds in leading biopharmaceutical organizations.
	Download: Benchmarking Real-World Uses of Artificial Intelligence in Medical Affairs: AI for Personalized Engagement and Key Lessons Learned (5745) This benchmark study probes how top companies are applying AI within Medical Affairs to enhance personalized engagement of external stakeholders, facilitate omnichannel implementation, and gather critical insights and take necessary actions.
	Download: Benchmarking Real-World Uses of Artificial Intelligence in Medical Affairs: AI for Data Analysis and Strategy (5746) This research investigates how top companies are applying AI within Medical Affairs to improve data analysis and evidence generation and unlock insights for better medical strategy and operations.